ScanSource, Inc. (SCSC) - Q2 2025 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended December 31, 2024 (Q2 Fiscal 2025) and the six months ended December 31, 2024. ScanSource, Inc. operates as a hybrid distributor connecting devices to the cloud, serving channel partners in hardware, SaaS, and connectivity services. The company operates primarily in the United States, Canada, and Brazil through two segments: Specialty Technology Solutions (wholesale model) and Intelisys & Advisory (agency model).
Key Financial Metrics
| Metric | Q2 2025 (Current) | Q2 2024 (Prior Year) | 6 Months 2025 (YTD) | 6 Months 2024 (YTD) |
|---|---|---|---|---|
| Net Sales | $747.5 million | $884.8 million | $1,523.1 million | $1,761.1 million |
| Gross Profit | $101.7 million | $100.7 million | $203.3 million | $207.3 million |
| Gross Margin | 13.6% | 11.4% | 13.4% | 11.8% |
| Operating Income | $18.4 million | $26.8 million | $36.1 million | $50.9 million |
| Net Income | $17.1 million | $32.7 million | $34.0 million | $48.2 million |
| Diluted EPS | $0.70 | $1.29 | $1.39 | $1.91 |
| Cash & Equivalents | $110.5 million | $45.0 million | $110.5 million | $45.0 million |
| Total Debt | $139.9 million | $144.1 million | $139.9 million | $144.1 million |
| Operating Cash Flow (6mo) | $38.6 million | $156.8 million | $38.6 million | $156.8 million |
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 15.5% year-over-year (YoY) for the quarter and 13.5% for the six months. The Specialty Technology Solutions segment saw a 16.0% decline, driven by lower large deals and cautious technology spending. The Intelisys & Advisory segment grew 4.0% due to recent acquisitions.
- Margin Expansion: Despite lower sales, gross margin improved significantly to 13.6% (from 11.4% YoY) due to a favorable sales mix and higher vendor program recognition.
- Profitability Pressure: Operating income fell 31.2% YoY to $18.4 million. This was driven by increased Selling, General, and Administrative (SG&A) expenses, specifically higher bad debt provisions in the U.S. and Canada, and restructuring costs.
- Acquisitions: The company completed two acquisitions in August 2024 (Resourcive and Advantix) with a combined initial purchase price of approximately $56.7 million, adding contingent consideration liabilities of $18.3 million.
- Restructuring: The company incurred $5.4 million in restructuring costs for the six months ended December 31, 2024, related to employee separation costs aimed at aligning cost structure with demand.
Guidance, Outlook, and Risks
- Outlook: Management expects the effective tax rate for fiscal year 2025 (excluding discrete items) to be approximately 28.5% to 29.5%. Capital expenditures for fiscal 2025 are projected to range from $8.0 million to $12.0 million.
- Share Repurchases: The Board approved a $100 million share repurchase authorization in May 2024. Approximately $71.0 million remains available under this program as of December 31, 2024.
- Liquidity: The company maintains a $350 million revolving credit facility with $350.0 million available. It remains in compliance with all financial covenants (Leverage Ratio < 3.50x; Interest Coverage Ratio > 3.00x).
- Risks: Key risks include macroeconomic weakness, supply chain challenges, credit risks with large customers, and foreign currency fluctuations (particularly the Brazilian Real). The company also faces ongoing legal proceedings and tax contingencies related to prior acquisitions, though management does not expect these to have a material adverse effect.
Investor Verification Checklist
- Bad Debt Provisions: Verify the sustainability of the increased bad debt expense in the U.S. and Canada, which significantly impacted operating income.
- Restructuring Savings: Monitor the realization of the projected $10.5 million in annualized savings from the September 2024 restructuring program.
- Acquisition Integration: Assess the performance contribution of the newly acquired Resourcive and Advantix businesses against the $56.7 million investment and associated earn-out liabilities.
- Working Capital Efficiency: Review the Days Sales Outstanding (DSO) of 66 days and inventory turnover of 5.2 times to ensure continued efficiency improvements.
- Foreign Currency Exposure: Evaluate the impact of the Brazilian Real on future earnings, as Brazil sales declined 32.5% YoY (reported) but only 18.9% on a constant currency basis.